Hippocratic AI is entering a new phase of growth, marked by the addition of seasoned leaders who bring deep expertise across healthcare sectors and global markets. This expanded executive team will help scale generative AI solutions into new areas, following strong momentum from the $141 million Series B funding round and the successful launch of Polaris 3.0. Designed with real-world insights from patients and clinicians, Polaris 3.0 has already demonstrated a high standard for safety and patient satisfaction, achieving a 99.38% clinical accuracy rate and an 8.95/10 patient rating.
The new leadership team includes professionals with proven track records in pharma, payor, provider, government, ambulatory care, and international operations. Their experience is set to support broader adoption of Hippocratic AI’s technology in both domestic and global healthcare ecosystems. With a shared commitment to improving access, efficiency, and outcomes, they will play key roles in advancing the company’s vision of healthcare abundance—where safe, effective care is made more accessible to people everywhere through responsible AI.